India-Brazil Trade is set for a major expansion as both countries target USD 30 billion in bilateral trade by 2030. The India-Brazil Trade partnership is also gaining momentum through wider market access for Indian pharmaceutical products.
India’s H1N1 cases continue to draw attention as more states strengthen surveillance and hospital preparedness. Jharkhand is now the latest state to step up its response after eight people tested positive for H1N1.
Regulatory actions from the USFDA and Maharashtra FDA dominated pharma news today. Companies secured key product approvals while others faced inspection findings and enforcement steps
The WHO science council has been renewed with 21 scientists and experts to help guide the future of global health. The World Health Organization announced the new membership.
The biggest pharma stories this week covered drug approvals, vaccines, medical devices, wellness investments, and emerging health research. These pharma stories also showed how quickly healthcare priorities are changing across India and global...
India is seeing an H1N1 flu surge, and flu vaccine demand has jumped sharply as influenza cases rise across the country. Vaccine sales are now nearly three times higher than last year. The demand has also more than doubled compared with July.
Drug development could see a major shift as Huawei expands its artificial intelligence partnerships with pharmaceutical companies
The Democratic Republic of Congo has started an Ebola vaccination campaign as cases and deaths continue to rise. The Ebola outbreak is driven by the rare Bundibugyo virus and has spread across six provinces.
Emergency care capacity in district hospitals will rise by 50 percent under a key Budget initiative that Health Minister J.P. Nadda reviewed on Thursday
FDA approval of updated COVID vaccines now lets manufacturers ship doses that target the XFG variant for the respiratory virus season
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")